Full name
CENTRUM MEDYCYNY TRANSLACYJNEJ SZKOŁY GŁÓWNEJ GOSPODARSTWA WIEJSKIEGO SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CENTRUM MEDYCYNY TRANSLACYJNEJ SZKOŁY GŁÓWNEJ GOSPODARSTWA WIEJSKIEGO SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. NOWOURSYNOWSKA 100, 02-797 WARSZAWA
TAX ID9512520380
Rate company:
CENTRUM MEDYCYNY TRANSLACYJNEJ SZKOŁY GŁÓWNEJ GOSPODARSTWA WIEJSKIEGO SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9512520380
KRS0000903373
Share capital20,000.00 zł
address
UL. NOWOURSYNOWSKA 100, 02-797 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9512520380
REGON
388660106
KRS
0000903373
Legal form
limited liability company
Register Address
UL. NOWOURSYNOWSKA 100, 02-797 WARSZAWA
Date of registration in KRS
2021-05-31
Date of commencement of economic activity
2021-05-31
Act signature
WA.XIII NS-REJ.KRS/20790/21/615/REGON
Pkd codes
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
75.00.Z - Veterinary activities
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
77.40 - Leasing of intellectual property and similar products, except copyrighted works
78 - Employment activities
82 - Office administrative, office support and other business support activities
85 - Education
86.21.Z - General medical practice activities
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss)  | 63,5 | 182,5 | 187,5 |
EBITDA | 63,5 | 183,2 | 188,4 |
Short time liabilities | 6,1 | 78,2 | 1183,2 |
Equity capital | 77,5 | 243,4 | 213,9 |
Operating profit (EBIT) | 63,5 | 183,2 | 188,4 |
Assets | 84,6 | 323 | 281,6 |
Net profit (loss) | 57,5 | 165,8 | 188,2 |
Cash | 83,6 | 79,1 | -5,3 |
Net income from sale | 164 | 322 | 96,3 |
Liabilities and provisions for liabilities | 7,1 | 79,6 | 1022,4 |
Working assets | 84,6 | 323 | 281,6 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 74,2 | 68,1 | -6,1 |
Equity capital to total assets | 91,6 | 75,3 | -16,3 |
Gross profit margin | 38,7 | 56,7 | 18 |
EBITDA Margin | 38,7 | 56,9 | 18,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 14 | 89 | 75 |
Current financial liquidity indicator | 11.930957794189453 | 4.056736469268799 | -7,8 |
Net dept to EBITDA | -1.3163597583770752 | -0.42772331833839417 | 0,9 |
Financial statements
01-01-2022 - 31-12-2022
Annual financial report
Download xml01-01-2022 - 31-12-2022
Annual financial report
Download pdf01-01-2022 - 31-12-2022
Activity report
Download xades01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Michał Ordak Ekspertstat
Warszawa
Wojciech Gładysz SCRA
Piskórka
SciencePlast Sp. z o.o.
Gdansk
KATARZYNA KRZYSTANEK
Częstochowa
FRONTLINE BIOSCIENCES SPÓŁKA AKCYJNA
WARSZAWA